These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6427375)

  • 1. Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model.
    Zuravleff JJ; Chervenick P; Yu VL; Muder RR; Diven WF
    J Lab Clin Med; 1984 Jun; 103(6):878-85. PubMed ID: 6427375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ; Yu VL; Yee RB
    J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
    Fainstein V; Bodey GP; Bolivar R; Elting L; McCredie KB; Keating MJ
    Arch Intern Med; 1984 Sep; 144(9):1766-70. PubMed ID: 6383246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients.
    Yu VL; Zuravleff JJ; Peacock JE; DeHertogh D; Tashjian L
    Antimicrob Agents Chemother; 1984 Oct; 26(4):575-7. PubMed ID: 6517547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of tobramycin-resistant S. epidermidis possessing aminoglycoside modifying enzymes and bacteremic superinfection during empiric therapy of febrile neutropenic episodes.
    Riben PD; Horsman GB; Rayner E; Irvine-Meek J; Urias B; Albritton WL; deSaxe MJ; Ronald AR; Louie TJ
    Clin Invest Med; 1985; 8(4):272-85. PubMed ID: 3907919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
    Maciá MD; Borrell N; Segura M; Gómez C; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):975-83. PubMed ID: 16495260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa].
    Liu MT; Sheng MY; Zhang Y; Li Y
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1427-31. PubMed ID: 21756818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.
    Ullmann U
    Chemotherapy; 1977; 23(5):314-23. PubMed ID: 409590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
    Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL
    Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract]   [Full Text] [Related]  

  • 17. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
    Plasencia V; Borrell N; Maciá MD; Moya B; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2574-81. PubMed ID: 17470655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa bacteremia: susceptibility of 100 blood culture isolates to seven antimicrobial agents and its clinical significance.
    Baltch AL; Hammer M; Smith RP; Sutphen N
    J Lab Clin Med; 1979 Aug; 94(2):201-14. PubMed ID: 110892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
    Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.